{
    "55046d5ff8aee20f27000007": "amphiregulin",
    "553fa78b1d53b76422000007": "miR-200a",
    "5149199dd24251bc05000040": "pyridostigmine",
    "5709e4b2cf1c32585100001c": "DVL-3",
    "54d4e03a3706e89528000001": "verapamil",
    "55072c803b8a5dc045000001": "Notch",
    "53061af558348c0f52000002": "arrested cell-cycle progression",
    "53137541e3eabad021000010": "c-Myc",
    "5718bbb37de986d80d00000b": "Alpers syndrome",
    "54f9d3eedd3fc62544000004": "calsequestrin",
    "515deafd298dcd4e51000025": "achalasia",
    "52bf202003868f1b06000018": "refractory partial-onset seizures",
    "56be0da3ef6e394741000007": "thrombocytopenia",
    "515a7ffdd24251bc050000a5": "inhibited cell migration",
    "56a92be0a17756b72f000009": "SoxB1",
    "56c3327c50c68dd41600000c": "C9orf72 (GGGGCC)\u00b7(GGCCCC) repeats",
    "5314a7a4dae131f847000003": "TNNC1-A31S",
    "56c6dd275795f9a73e000008": "H3K9me3",
    "5322d9339b2d7acc7e000011": "apoptosis",
    "56c1f005ef6e39474100003a": "interleukin-13",
    "513ce3c8bee46bd34c000008": "FGFR2",
    "56d06e043975bb303a000011": "advanced, oestrogen receptor-positive, HER2-negative breast cancer",
    "571e1e11bb137a4b0c000004": "urinary tract and genital infections",
    "56a3a386496b62f23f000007": "JASPAR 2014",
    "56c1f038ef6e394741000051": "photophobia",
    "571529efcb4ef8864c000001": "colchicine",
    "53358cd2d6d3ac6a3400004e": "ichthyosis",
    "52b2d405f828ad283c000009": "synovial fibroblasts",
    "518cb4b5310faafe08000006": "lithium carbonate",
    "552faa43bc4f83e828000004": "BCL11B",
    "533c3af6c45e13371400000d": "familial cylindromatosis",
    "571f3b320fd6f91b68000007": "hirsutism",
    "54d65b6b3706e8952800000c": "PMP22",
    "517a8c918ed59a060a000043": "Coxsackie B viruses",
    "571f2b5bbb137a4b0c000010": "PDCD10",
    "550320cbe9bde6963400002d": "hypodontia",
    "511a4d391159fa8212000003": "MET",
    "517137c18ed59a060a000001": "DNA-binding protein 2",
    "531d7430267d7dd053000008": "clonazepam",
    "5523f1a62c8b63434a000002": "Arg14del",
    "52df8ce798d023950500000d": "Cr",
    "5505b9ff8e1671127b000001": "Atg8",
    "57090784cf1c325851000011": "myelodysplastic syndrome",
    "55414a763f2354b713000003": "ExTopoDB",
    "56ebfa13107309bc2f000004": "gene expression",
    "533c2230c45e133714000002": "innate immunity",
    "514241fcd24251bc05000006": "paraspeckle component 1",
    "56f802ea09dd18d46b000017": "SHMT2",
    "531376c8e3eabad021000012": "PLN -42 C>G",
    "5312280ce3eabad02100000a": "12",
    "54df69af1388e8454a000005": "fluorouracil",
    "5536554abc4f83e828000008": "D22S1 and D22S15",
    "56f3f0f02ac5ed1459000017": "CPModule",
    "532ad23ad6d3ac6a34000011": "IMGT",
    "5156be75d24251bc05000088": "osteosarcoma",
    "57169b63cb4ef8864c00000b": "glutamate transporter-1 (GLT-1",
    "55184d46622b194345000001": "colloidal Coomassie Blue",
    "54cf43abf693c3b16b000008": "sagittal",
    "55391ce8bc4f83e828000018": "Myc",
    "51542dc3d24251bc0500007e": "fever",
    "51595fb0d24251bc0500009c": "Mage-A4",
    "5547d700f35db75526000007": "ataxic dysarthria primarily caused by cerebellar dysfunction, and hyperkinetic dysarthria",
    "531b1e3cb166e2b80600003b": "H3K27me3",
    "52d832dd98d0239505000003": "pS-X-X-S",
    "56bb616dac7ad10019000008": "Rivaroxaban",
    "56b3a3ce8525abca1e000005": "perilipin",
    "535d59349a4572de6f000009": "iron-restricted anemia",
    "56c1d84cef6e394741000031": "brainstem reflexes",
    "5713bf261174fb1755000011": "ear",
    "5503263fe9bde69634000030": "congenital cataracts",
    "5309f8f5970c65fa6b000001": "Ras",
    "5517f9286487737b43000002": "junctin",
    "56d1d94667f0cb3d66000005": "cancer development",
    "56d29d4df22319765a000003": "Proteomics",
    "52ea605098d0239505000028": "MYH7",
    "5318367cb166e2b806000012": "PINK1",
    "56be06cdef6e394741000004": "chorioretinitis",
    "515d1ff7298dcd4e51000009": "invasion, and growth",
    "56ed27202ac5ed145900000c": "macrophages",
    "55424745ed966d112c000002": "gamma-bases",
    "530cf4e0c8a0b4a00c000004": "Arg403-->Gln",
    "530cf4e0c8a0b4a00c000005": "mitral valve prolapse",
    "52e0141498d023950500000e": "growth retardation",
    "5518e817622b194345000006": "N-Ras",
    "530cefaaad0bf1360c000003": "Alemtuzumab",
    "530cefaaad0bf1360c000002": "nucleus accumbens",
    "52ecf2dd98d023950500002e": "Ala92",
    "5319abe4b166e2b80600002e": "Slug",
    "54ff30dc6ad7dcbc1200000f": "Prader Willi Syndrome",
    "530cefaaad0bf1360c000011": "headache, muscle and joint pain",
    "55031628e9bde69634000024": "medullary thyroid carcinoma, gastroenteropancreatic tumors, pheochromocytoma",
    "530cefaaad0bf1360c00000c": "pentostatin",
    "54d670163706e8952800000f": "HSPG2",
    "5324cf139b2d7acc7e00001f": "fibromyalgia syndrome",
    "54cf705ff693c3b16b000014": "\u03b1v\u03b25",
    "5171a1498ed59a060a000012": "MYD88",
    "54d77bdf3706e89528000019": "22",
    "56be0a18ef6e394741000006": "pleural effusion",
    "5311b99ae3eabad021000004": "blood urea nitrogen",
    "5131fa145274a5fb07000009": "cystic fibrosis",
    "51630226298dcd4e5100004d": "selective detection of PTMs to automatically screen for acetylation, phosphorylation, and methylation",
    "5505eed08e1671127b000006": "trypsin",
    "55451e53bf90a13052000003": "Mfd",
    "52eea509c8da89891000000d": "KCNH2",
    "54e1252fae9738404b000003": "dystrophic scarring and joint hypermobility",
    "517a8bef8ed59a060a000041": "D3",
    "5148885ad24251bc05000032": "VKORC1",
    "571e189dbb137a4b0c000003": "empagliflozin",
    "52bf1f4503868f1b06000016": "schizophrenia",
    "52eeddfcc8da898910000010": "periodic paralysis",
    "56f56a8609dd18d46b00000b": "SPINK5",
    "54fb6fb5d176fff445000004": "CSL",
    "532c0c21d6d3ac6a3400001b": "Cat-Scramble methodology",
    "5166f41a298dcd4e5100005b": "BIX-01294",
    "517539af8ed59a060a000026": "calsequestrin",
    "52d2818403868f1b06000033": "ZFN",
    "571cd9537de986d80d00000e": "CASPASE-1",
    "553c994af32186855800000b": "Drosophila melanogaster",
    "54e061ee1388e8454a00000c": "everolimus",
    "553d061cf321868558000013": "TFCONES",
    "56c1f043ef6e394741000057": "MT2",
    "5318380bb166e2b806000013": "PICK1",
    "5173b5ea8ed59a060a00001f": "H3K36me3",
    "5324cca79b2d7acc7e00001d": "dermatology",
    "54f431d664850a5854000006": "TINF2",
    "5354f289288f4dae47000008": "MITIE",
    "570a5343cf1c325851000022": "R160W",
    "5713b29f1174fb175500000f": "Silver syndrome/spastic paraplegia 17",
    "5141bcd423fec9037500000d": "SCH-527123",
    "52bf1af803868f1b06000008": "CPVT",
    "550303a5e9bde6963400000c": "chronic obstructive pulmonary disease",
    "51bdf045047fa84d1d000003": "GABARAPL1",
    "515db020298dcd4e51000011": "2009-016278-34",
    "533c2a55c45e133714000003": "YAPYAP1",
    "5548da00f35db7552600000b": "myosins-Ibeta, -VI, and -VIIa",
    "530db83b38c1322806000002": "I\u03baBs",
    "56c1f007ef6e39474100003b": "glioblastoma",
    "56e46ad951531f7e3300001a": "tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3",
    "530cf22aa177c6630c000005": "Mrc1 and Ctf4",
    "56bf487def6e394741000011": "Aip1, Ede1",
    "5543a1b2ee40ea110c000001": "etioplasts",
    "56cf2be73975bb303a000005": "monoclonal anti-IL-5 antibodies",
    "5713bc991174fb1755000010": "GDAP1",
    "54fb4b34d176fff445000001": "c-Jun",
    "56a39a32496b62f23f000005": "ddgraph",
    "515de993298dcd4e51000024": "Mindfulness-based therapy",
    "54fc9b236ad7dcbc12000005": "istradefylline",
    "54fe09036ad7dcbc12000009": "AFP",
    "517295c18ed59a060a000016": "microRNAs and snoRNAs",
    "5505c9008e1671127b000002": "Rictor",
    "5326c6fed6d3ac6a3400000c": "Type 2 diabetes mellitus",
    "5319a6c9b166e2b806000022": "vatalanib",
    "56a37e33496b62f23f000003": "palindromic sequences",
    "571ce13f7de986d80d000011": "sebocytes",
    "533c3533c45e133714000004": "miR-146a",
    "52f112bb2059c6d71c000002": "RNMT",
    "5358e067f1005d6b5800000b": "CRP1",
    "56e0447a51531f7e3300000b": "viroids",
    "52f893f92059c6d71c00003c": "androgen replacement therapy",
    "56bdfa73ef6e394741000003": "urinary incontinence",
    "56f96333cf1c325851000004": "disulfide bonds",
    "54c90dabf693c3b16b000004": "SERCA2a",
    "52f8995b2059c6d71c00004a": "BTBD9",
    "52bf1dea03868f1b06000012": "nausea, dizziness, and insomnia",
    "530cf4d5e2bfff940c000004": "Knowledge Network Gene Prioritization (KNGP) algorithm which can incorporate both link and node knowledge In recent years, network-based methods",
    "5537766dbc4f83e82800000d": "dwarfism, microtia",
    "55439140ed966d112c00000a": "C-phycocyanin",
    "517539ca8ed59a060a000027": "TRalpha1",
    "554143ad182542114d000004": "MetaTM",
    "56b739d976d8bf8d13000005": "Brainbow",
    "5319abffb166e2b80600002f": "fibroblast growth factors",
    "534bb147aeec6fbd07000014": "negative inotropic and chronotropic action was produced, and the resistance to ischemic injury",
    "55086ea1098a1b487b000001": "non-small cell lung cancer",
    "5171651e8ed59a060a000009": "Human kallikrein-related peptidase 3",
    "55414c65472cfd8617000001": "askHERMES",
    "517a8c238ed59a060a000042": "iodothyronine",
    "530e1c985937551c09000004": "osteodystrophy",
    "516c0ebc298dcd4e5100006e": "GH gene in GH3-PV and ME",
    "5713b0a51174fb175500000e": "Arts syndrome",
    "56c8605b5795f9a73e000014": "JAK1 and JAK2",
    "550b0408c2af5d5b7000000c": "Aptamers",
    "51477de5d24251bc05000020": "pancreatic islets and anterior pituitary glands",
    "5524562387ecba3764000001": "Sonic Hh, Indian Hh, and Desert Hh",
    "51486f7dd24251bc0500002e": "9-item Patient Health Questionnaire (PHQ-9",
    "52ef7754c8da898910000014": "DNA",
    "5319a724b166e2b806000025": "dentatorubral-pallidoluysian atrophy",
    "53188992b166e2b806000019": "BCR-ABL",
    "52ebb2c698d0239505000029": "renal angiomyolipomas",
    "54f0920f94afd61504000018": "cisplatin",
    "57220e400fd6f91b68000015": "fatigability",
    "553babc0f321868558000007": "anaerobic Gram-negative",
    "5162c8a8298dcd4e51000047": "CCR4",
    "56a3bf0f496b62f23f00000a": "GenomicFeatures",
    "516281e6298dcd4e51000040": "SIMAC",
    "56c3326750c68dd41600000b": "H3K36me3",
    "54d646403706e89528000008": "major depressive disorder",
    "5172f8118ed59a060a000019": "Endopterygota",
    "534df8c9aeec6fbd07000016": "multiple sclerosis",
    "56e30dd551531f7e33000016": "CLOCK",
    "530e0d6e5937551c09000001": "subarachnoid aneurysm trial",
    "5311bf53e3eabad021000006": "flutemetamol",
    "515bd543298dcd4e51000001": "GC-rich",
    "52e6c92598d0239505000019": "codon 12, 13 and 61",
    "531778ddb166e2b80600000f": "adrenocortical cancer",
    "52fb42752059c6d71c00005e": "TRIAC",
    "5509b6d22e93f0133a000005": "surgical resection",
    "56be0e4aef6e394741000008": "bronchiectasis and sinusitis",
    "54dfc6501388e8454a000009": "host-mediated defense",
    "52e0c9a298d0239505000010": "H4K20me3, H3K9me3",
    "51487ef9d24251bc05000031": "entacapone",
    "5505db6a8e1671127b000003": "intermediate filaments",
    "56c9f9d95795f9a73e00001e": "aggregate, be recruited to stress granules and alter paraspeckle integrity",
    "54c225bcf693c3b16b000002": "CASQ2",
    "532c0d7fd6d3ac6a3400001c": "LigandScout",
    "530c844e970c65fa6b000014": "Leber's hereditary optic neuropathy plus dystonia",
    "571653aecb4ef8864c000005": "nanoplasmonics",
    "517a8bab8ed59a060a000040": "iodothyronine deiodinase (D3",
    "5149a61ed24251bc05000044": "BETAWARE",
    "56c33e5695c1e7cc5b000001": "pericentromeric heterochromatin",
    "5547a7e9f35db75526000006": "UvrC",
    "570921e4cf1c325851000017": "genes",
    "56bcdf1ad36b5da378000009": "prostate cancer",
    "56bcc455d36b5da378000003": "NBEAL2",
    "52f89fd32059c6d71c000051": "FOG-1",
    "533675ced6d3ac6a34000056": "H2AX",
    "52f895602059c6d71c000040": "blood pressure",
    "551829a76487737b43000009": "asthma",
    "52bf209303868f1b0600001a": "ischemic stroke",
    "55152bd246478f2f2c000002": "caveolin-1 and IQGAP1",
    "516c3960298dcd4e51000073": "Dnmt3",
    "54e0ac041388e8454a00000f": "Ty3/gypsy-like",
    "553a7a59f321868558000002": "FOG-1",
    "52f129d92059c6d71c000009": "Friedreich ataxia",
    "55192f20622b194345000014": "c-Rel",
    "571e417bbb137a4b0c00000a": "coproporphyrinuria",
    "52fa73e82059c6d71c000059": "Agrobacterium-mediated",
    "554397f6ed966d112c00000c": "Fcy21p",
    "551910d3622b194345000008": "persephin and GDNF",
    "5314b20bdae131f847000005": "fava beans",
    "52fb78d82059c6d71c000068": "c.664C>T; p.Arg222X",
    "535d5bac7d100faa09000001": "Cardiovascular events",
    "55031270e9bde6963400001a": "Shwachman-Diamond syndrome",
    "56d2ac03f22319765a000004": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
    "515870cdd24251bc0500008f": "OXA-48",
    "52f4f1d62059c6d71c00001c": "sick sinus syndrome",
    "533c384dc45e133714000006": "promoter region",
    "54e071e11388e8454a00000d": "fludarabine, cytarabine",
    "5506e2ff8e1671127b00000d": "IKK\u03b2",
    "53189b05b166e2b80600001e": "salivary",
    "51716a438ed59a060a00000a": "GeneMark",
    "514168ab23fec9037500000a": "c-Myc",
    "53215fca9b2d7acc7e000005": "MINOS",
    "515c4f05298dcd4e51000006": "KCNE1",
    "56ae40110a360a5e45000009": "DEEP",
    "5311d130e3eabad021000009": "tau",
    "52f509232059c6d71c00001f": "KCNJ2",
    "56be1723ef6e39474100000c": "facial pain",
    "550e9d2cb305b40c5c000001": "Age",
    "516c0ed3298dcd4e5100006f": "pyruvate kinase mRNA",
    "516ec97f298dcd4e51000087": "bootstrap and jackknife",
    "5324d0169b2d7acc7e000022": "finasteride",
    "54fc9ca16ad7dcbc12000006": "orexin",
    "515d7693298dcd4e5100000c": "keratin contaminants",
    "56c1f030ef6e39474100004d": "epilepsy",
    "550312b4e9bde6963400001c": "RPL11",
    "51492168d24251bc05000041": "Hamilton",
    "56d8b47a51531f7e33000004": "congenital sensorineural deafness, goiter",
    "54edaee3445c3b5a5f000003": "B. afzelii (serotype 2), B. garinii",
    "5506eca18e1671127b00000f": "p65 and p50",
    "5335d4e8d6d3ac6a34000053": "endothelin receptor antagonist",
    "518ba4b5310faafe08000005": "fluticasone",
    "54db7c4ac0bb8dce23000001": "protein kinase A",
    "56f8077a8b98c98849000002": "limbic encephalitis",
    "5503145ee9bde69634000022": "follicular thyroid carcinoma",
    "55391825bc4f83e828000016": "deafness",
    "56be15ffef6e39474100000b": "atrial septal defect",
    "5333f728d6d3ac6a34000041": "na\u00efve Bayes classifier non-interacting proteins (NIPs",
    "51434c74d24251bc0500000c": "TMBETAPRED-RBF",
    "5150f401d24251bc05000075": "sildenafil",
    "51601071298dcd4e51000038": "Neisseria meningitidis",
    "515993f3d24251bc050000a0": "GC-1",
    "53357c98d6d3ac6a3400004a": "BRCA)2",
    "5523e47f7b523f2123000004": "mCherry",
    "54fb5720d176fff445000002": "c-Myc",
    "5363bad27d100faa0900000e": "ci-ankrd52",
    "532b15ecd6d3ac6a34000014": "doxorubicin",
    "56c830635795f9a73e00000e": "TDP-43",
    "5720a8da0fd6f91b68000010": "sleep apnea",
    "54d8d60d014675820d000007": "vemurafenib or dabrafenib",
    "531375a6e3eabad021000011": "J wave",
    "56d1e23c67f0cb3d66000009": "TAZ",
    "531b3ff3b166e2b80600003d": "aPKC",
    "5314c7afdae131f84700000a": "hyperhidrosis",
    "52f5417b2059c6d71c000024": "C58/J",
    "5717ab7ccb4ef8864c00000c": "stress granule formation",
    "56c6dc6f5795f9a73e000007": "H3K79me3",
    "56f5692f09dd18d46b00000a": "TREX1",
    "530a3e18970c65fa6b000005": "Chromobacterium) and the Firmicutes dominated the biostimulated aquifer community.Shewanella oneidensis",
    "570a922dcf1c325851000028": "necroptosis",
    "5173eb428ed59a060a000021": "T-cell leukemia",
    "51bdb644047fa84d1d000001": "NDC1NDC1",
    "534ab91eaeec6fbd07000012": "hepaCAM",
    "51740da48ed59a060a000024": "SCGPred",
    "51766e438ed59a060a000031": "SECp43",
    "552435602c8b63434a000009": "p16INK4A (P16",
    "54f21b69c409818c32000007": "Juvenile hemochromatosis",
    "52e203bc98d0239505000011": "TGC",
    "515df86a298dcd4e5100002e": "breast cancer",
    "56be2570ef6e39474100000d": "conscientiousness",
    "5322d3cb9b2d7acc7e000010": "HDAC6",
    "515de748298dcd4e51000023": "gastrointestinal stromal tumors",
    "54dfbed11388e8454a000008": "APOBEC3",
    "5149aafcd24251bc05000045": "PPIs",
    "51600ab3298dcd4e51000036": "frontotemporal dementia",
    "56c1f000ef6e394741000037": "trifluridine",
    "515db20e298dcd4e51000014": "cognitive-behavioural therapy",
    "54cf6d40f693c3b16b00000e": "icatibant",
    "515bf6d6298dcd4e51000004": "colitis",
    "530cf4fe960c95ad0c000007": "hypertension",
    "52bf1cb303868f1b0600000b": "craniosynostosis with symmetrical syndactyly",
    "5539029cbc4f83e828000012": "Myt1L, Nfia",
    "5300aad02059c6d71c000080": "baseball/softball and football",
    "553e1aa5a3cf796f71000003": "deletion mutations",
    "56c08702ef6e394741000024": "Erythropoietic Protoporphyria",
    "56c1f034ef6e394741000050": "parkinsonism",
    "571f5d3e0fd6f91b6800000a": "Huntington's disease",
    "52fc94db2059c6d71c000074": "bapineuzumab",
    "516e5f25298dcd4e5100007d": "Etoposide",
    "52fc8b772059c6d71c00006e": "1,7-naphtyridine-3-carbonitrile",
    "5324d0429b2d7acc7e000023": "central serous chorioretinopathy",
    "553fca6054168f6c79000002": "MutY, MutM, and MutT",
    "52ee065d98d0239505000033": "prostate, and colon cancer",
    "56d094f33975bb303a000012": "cell division",
    "550e866271445a662f000005": "prostate cancer",
    "56acc7ca0a360a5e45000002": "Insyght",
    "515ffc2b298dcd4e51000035": "Aspergillus terreus",
    "5321badd9b2d7acc7e00000a": "melanoma",
    "5540eda30083d1bf0e000006": "MutSL",
    "56cdf3745795f9a73e000039": "mLST8",
    "5508685b4b2a315d4100000a": "Crohn's disease",
    "553fac39c6a5098552000001": "polC",
    "56cf4b623975bb303a00000a": "serotonin",
    "52bf1d6003868f1b0600000e": "Type 2",
    "515c4f1f298dcd4e51000007": "HCN4",
    "553f96191d53b76422000004": "in situ end labeling",
    "54de15f91388e8454a000002": "APOBEC3F",
    "5306158358348c0f52000001": "SNRPN",
    "5149af96d24251bc05000046": "MosaicFinder",
    "56e460d051531f7e33000019": "heightened sensitivity to light",
    "514a11add24251bc05000054": "breast cancer",
    "5165932e298dcd4e51000059": "5-azacytosine",
    "5131bef65274a5fb07000008": "H3K4me2 as a mark for active enhancersHyperacetylation of histones H3 and H4",
    "5516757c46478f2f2c000008": "Nmd2p",
    "5160412d298dcd4e5100003c": "H4-K20",
    "54df6ed91388e8454a000007": "radiotherapy",
    "54e22b62ae9738404b000011": "COL5A1 and COL5A2",
    "551adceb622b194345000018": "blood pressure",
    "532f0b2cd6d3ac6a3400002c": "dural ectasia, protrusio acetabuli, and ligamentous laxity",
    "5512c1ee6a8cde6b72000009": "p38\u03b3, and p38\u03b4",
    "515db70c298dcd4e51000017": "insomnia",
    "54fb5c69d176fff445000003": "Mef2c",
    "5357b9bcf1005d6b58000008": "S19",
    "5542644fed966d112c000004": "correlation",
    "55242d512c8b63434a000006": "5-hydroxytryptamine type 2a",
    "550316a6e9bde69634000029": "type 1 diabetes",
    "513f45abbee46bd34c000013": "adipose tissues",
    "56ddbbaf51531f7e33000009": "H3K27me3",
    "517843638ed59a060a000036": "Alu, L1, and SVA",
    "55031286e9bde6963400001b": "reticulocytopenia",
    "533ec7abc45e133714000015": "NELF",
    "54ecb640445c3b5a5f000001": "pancytopenia",
    "513f3d1fbee46bd34c000010": "raloxifene",
    "553f7a71ab98a37113000009": "illegitimate recombinationTranscription-coupled repair",
    "53355befd6d3ac6a34000046": "HADDOCK",
    "52f89f4f2059c6d71c00004e": "NBEAL2",
    "550712739d0faaa527000008": "RYR2-S4153R",
    "511a20f3df1ebcce7d00000c": "psoriatic arthritis",
    "518cca6f310faafe0800000a": "miR-221",
    "5717cdd2070aa3d072000001": "Cyclosporine A",
    "56d1fd67f22319765a000002": "Treponema denticola",
    "56df03c751531f7e3300000a": "stability",
    "517775c78ed59a060a000033": "Memantine",
    "54e0dfa91388e8454a000018": "Med70",
    "517539e68ed59a060a000028": "NADH dehydrogenase subunit 3",
    "518cb5ab310faafe08000008": "quadruple therapy",
    "570a6d03cf1c325851000025": "gremlin-1",
    "56cd765b5795f9a73e000038": "energy starvation",
    "5326300fd6d3ac6a34000005": "contrast-enhanced MR cisternography",
    "51be411b047fa84d1d000006": "LaTcOm",
    "54db7217c4c6ce8e1d000003": "RyR3",
    "5506a7a48e1671127b000008": "protein phosphatase 2B",
    "532c0ac4d6d3ac6a3400001a": "pharmacokinetic properties",
    "52e7b7cb98d023950500001c": "enistein",
    "5895f9cf78275d0c4a000002": "lymphoedema",
    "58a2fac960087bc10a000009": "hepatotoxicity",
    "589c215778275d0c4a00003c": "tyrosine hydroxylase",
    "5896deff78275d0c4a000013": "ledipasvir",
    "58a7fb2860087bc10a000034": "SLITRK1",
    "588fd8f3621ea6ff7e000001": "BLUEPRINT",
    "58846be0e56acf5176000005": "essential tremor",
    "58839d892305cd7e21000006": "microRNA genes related to reproduction",
    "58919aad621ea6ff7e00000d": "Fulvestrant",
    "587d2700fe8a08052f000001": "dbSUPER",
    "58a2efec60087bc10a000008": "neuronal loss",
    "58a45d6060087bc10a00001d": "Stevens-Johnson syndrome",
    "58a0da5278275d0c4a000054": "Polyneuropathy",
    "58932cd87d9090f353000001": "Velocardiofacial syndrome",
    "589a246378275d0c4a00002c": "epilepsy",
    "589c42b178275d0c4a00003f": "fibrates and statins",
    "58a326da60087bc10a00000e": "sibutramine",
    "589aec4778275d0c4a000037": "cryptococcal",
    "58a0c09778275d0c4a000052": "Sulphonylurea",
    "5883bce3e56acf5176000003": "Q-nexus",
    "5884fe4ce56acf5176000010": "cervical cancer",
    "58a3275960087bc10a00000f": "conjunctivitis",
    "58a80bc838c171fb5b000001": "Cdk1",
    "58a94483ee23e0236b000003": "IV",
    "58bd645702b8c60953000010": "Gordon syndrome",
    "58bc666702b8c60953000004": "Parkinson's disease",
    "58bbb71f22d3005309000016": "RMBase",
    "58bc9a5002b8c60953000008": "elevated liver enzymes",
    "58bbbe6822d300530900001a": "Proteobacteria",
    "58b53bf722d3005309000004": "orofacial edema, recurrent facial paralysis, and a fissured tongue",
    "58850e50e56acf5176000013": "Glasgow Coma Scale",
    "589dee3778275d0c4a000050": "ALK2",
    "58b52c8822d3005309000001": "Ascher's syndrome",
    "58a8071760087bc10a000037": "CID and HCD",
    "588f220e3b87a8a73800000d": "CIRCexplorer",
    "589a245878275d0c4a000025": "Tokuhashi",
    "589c4c9078275d0c4a000040": "gastrointestinal symptoms",
    "58962ed178275d0c4a000006": "sacubitril/valsartan",
    "58ca746d02b8c6095300002d": "adipocytes",
    "588f952994c1512c50000007": "optic nerve hypoplasia",
    "58a71f7460087bc10a00002e": "H3",
    "58c66a4b02b8c60953000025": "kernicterus",
    "58adb9919ef3c34033000004": "HDAC2",
    "58bfcb8702b8c60953000016": "lichen sclerosus",
    "58c6a6c502b8c60953000027": "vertigo",
    "58ce5c7c1f5fb2b734000001": "BB-3497",
    "58de71fa8acda3452900002c": "INO80",
    "58ca6d3902b8c6095300002c": "Waldmann's disease",
    "58c99acf02b8c60953000028": "arthroscopic debridement",
    "58948cb47d9090f353000008": "Mcidas",
    "58cd59cb02b8c60953000039": "attention deficit hyperactivity disorder",
    "58b548d722d3005309000005": "Corynebacterium diphtheriae",
    "589a245a78275d0c4a000026": "topiramate",
    "589a246178275d0c4a00002b": "warfarin",
    "58cea0768acda34529000001": "Tay-Sachs disease",
    "58c1b2f702b8c6095300001e": "obesity",
    "587d2b7efe8a08052f000003": "130",
    "58add1d79ef3c34033000008": "PIK3CA (n\u2009=\u20092), FGFR1",
    "58dfd83a6fddd3e83e000003": "ANGPTL3",
    "58c6665602b8c60953000024": "acute hemolysis, chronic hemolysis",
    "58d8e9bd8acda3452900000b": "heart failure",
    "58d8d8108acda34529000009": "ADAMTSL4",
    "5880b2a6c872c95565000004": "interleukin-13",
    "58e0035f6fddd3e83e000009": "actin filaments, microtubules, and intermediate filaments",
    "5880b583c872c95565000005": "Everolimus-Eluting Stent Versus Coronary Artery Bypass Surgery",
    "58add7699ef3c34033000009": "Pap1",
    "587d30fb31b33e8760000001": "EP-DNN",
    "58a6c94860087bc10a00002a": "H3F3A K27M",
    "58da5b588acda34529000015": "headache",
    "58da5dc58acda34529000016": "CRS type 4",
    "58dcecf58acda34529000023": "MCM",
    "58eb2887eda5a57672000003": "BWA",
    "58da14178acda34529000011": "21",
    "58ea59273e8b6dc87c000012": "herpes simplex viral",
    "58dd07488acda34529000025": "thrombocytopenia",
    "5895b7157d9090f353000009": "microcephaly",
    "58f4b73b70f9fc6f0f000014": "mumps and rubella",
    "5895bfdc7d9090f35300000c": "achalasia",
    "5895dd6a7d9090f35300000f": "idiopathic retinal vasculitis, aneurysms, and neuroretinitis",
    "58dbb3f18acda34529000019": "evolocumab",
    "5895dfc97d9090f353000010": "elvitegravir",
    "5895e4637d9090f353000012": "Metaphyseal dysplasia",
    "58e7a1393e8b6dc87c00000b": "FCGR2A",
    "5895e9977d9090f353000013": "macular dystrophy",
    "58e640573e8b6dc87c000003": "circRNA_finder, find_circ, CIRCexplorer",
    "58adca6d9ef3c34033000007": "Nab3",
    "58eb6061eda5a57672000005": "compression",
    "589a246c78275d0c4a000032": "topiramate",
    "58da2a348acda34529000014": "alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol",
    "5a6d0b2db750ff445500002d": "CUL-2 and UBXN-3",
    "5a7238d32dc08e987e000009": "sodium-glucose cotransporters 1",
    "5a894f6abc7bade53a000004": "liver damage",
    "5a76196faacfb9cd4c000001": "immune thrombocytopenia",
    "5a82fc89faa1ab7d2e000028": "H3K4me3",
    "5a882b5761bb38fb24000013": "Aicardi-Goutieres syndrome",
    "5a6d1143b750ff445500002e": "Ufd1-Npl4",
    "58f8a08370f9fc6f0f00001b": "patella dislocations",
    "5a43b2d7966455904c00000c": "CircTest DCC",
    "5a68ff52b750ff445500001c": "extensor pollicis brevis",
    "590c740d70f9fc6f0f00001d": "Osh7p, which have been implicated in regulating intracellular lipid and vesicular transportSterol metabolism and ERG2",
    "5925227670f9fc6f0f000020": "JBP1",
    "5a737b483b9d13c70800000b": "Pembrolizumab versus ipilimumab",
    "58ee2515eda5a57672000016": "45-year-old patient",
    "5a67afb7b750ff445500000d": "Polyneuropathy",
    "5a678d63b750ff4455000003": "redness, heat, swelling and pain",
    "5a70dbe599e2c3af26000004": "SMAD4",
    "5a70ce4ab750ff4455000064": "SERPINH1",
    "5a736efc3b9d13c708000006": "11",
    "5a8a9abdfcd1d6a10c000019": "RIO3, TEX27",
    "5a7723b79e632bc06600000b": "decline in growth rate",
    "5a7727f39e632bc06600000d": "growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts",
    "5a86f074faa1ab7d2e00003a": "Chordoma",
    "5a75fbf383b0d9ea6600000a": "ulcerative colitis",
    "5a76155c83b0d9ea6600001e": "RA-BUILD study",
    "5a67a207b750ff4455000008": "prophylactic",
    "5a89a20ffcd1d6a10c00000e": "vascular endothelial growth factor",
    "5a86ebf2faa1ab7d2e000038": "CLOCK",
    "5a7600b983b0d9ea6600000c": "Psoriasis Trial (OPT) Compare Study (NCT01241591",
    "5a7244aa2dc08e987e00000f": "interleukin 12/23",
    "5a8842a261bb38fb24000015": "S100A9",
    "5a86c938faa1ab7d2e000034": "IAA5 and IAA19",
    "5a76018c83b0d9ea6600000e": "MPygopagus",
    "5a6a2dcab750ff4455000023": "developmental regulatory target genes",
    "5a7636d39e632bc066000004": "pmsignature",
    "5a981e66fcd1d6a10c00002f": "dyslipidemia",
    "5a8861eb8cb19eca6b000001": "synaptophysin",
    "5a68f965b750ff445500001a": "Gardnerella",
    "5a68fd01b750ff445500001b": "p24",
    "5a6f7e6ab750ff4455000052": "Beneficence, Respect for autonomy",
    "5a70d12899e2c3af26000001": "facial nerve paralysis",
    "5a8afbf2fcd1d6a10c00001c": "tiger",
    "5a8dc6b4fcd1d6a10c000026": "infliximab",
    "5a75dff883b0d9ea66000003": "Cistrome Data Browser",
    "5a760e5583b0d9ea66000018": "FANTOM CAGE",
    "5a75ee7e83b0d9ea66000005": "jaundice",
    "5a75df9883b0d9ea66000002": "gastric leiomyosarcoma",
    "5a981bcffcd1d6a10c00002d": "ophthalmoplegia",
    "5a7486a90384be9551000003": "VEGF",
    "5a7240aa2dc08e987e00000d": "bezlotoxumab",
    "5aa80873d6d6b54f79000013": "Nucleostemin",
    "5aacdcf1fcf4565872000009": "BRD4",
    "5a9eb008d6d6b54f79000001": "Europe, that in the Eastern United States of America",
    "5aa55b65d6d6b54f7900000e": "erythema infectiosum",
    "5a736f0c3b9d13c708000007": "13",
    "5a7339372dc08e987e000013": "sofosbuvir/velpatasvir",
    "5a76344e9e632bc066000003": "SAMZIP",
    "5aa13fd3d6d6b54f79000003": "methadone, buprenorphine",
    "5aa82388fcf4565872000001": "glutathione S-transferase",
    "5a9d96564e03427e73000001": "hypertension",
    "5a9d2dd21d1251d03b00001a": "V1V2 glycan site",
    "5ac7185f0340b9f058000004": "autophagy",
    "5ac721230340b9f058000005": "circ-ABCB10",
    "5abcf755fcf4565872000028": "herpes zoster",
    "5ace20fa0340b9f05800000c": "EPAS1, EGLN1, and PPARA",
    "5a99566e1d1251d03b00000f": "antisocial personality disorder",
    "5abd2ce0fcf456587200002a": "Bacteroidetes and Firmicutes",
    "5aac5469fcf4565872000005": "loss of appetite, and nausea or vomiting.The illness was characterized by fever, headache, myalgia",
    "5a7d5580faa1ab7d2e00001a": "[(18)F]THK523, [(18)F]THK5117",
    "5ac2776195d0062724000006": "Dentatorubral-pallidoluysian atrophy",
    "5abd44b1fcf4565872000030": "HEATR1",
    "5ac0f7b919833b0d7b000006": "ciraparantag",
    "5ace34eb0340b9f058000010": "Keratin 14",
    "5aae6a86fcf456587200000e": "UV-B",
    "5aaef38dfcf456587200000f": "heart failure, diabetes",
    "5abce6acfcf4565872000022": "fluorouracil",
    "5ad303970340b9f05800001a": "inflammatory",
    "5c34ad63da8336e21a000007": "noncoding DNA",
    "5c55de1607647bbc4b00000a": "myelokathexis",
    "5be47df8133db5eb78000019": "Oscillospira and/or Ruminococcus",
    "5ad4eddf133db5eb78000009": "Protein-Protein Interaction Database",
    "5c5f03371a4c55d80b000009": "Pcp1",
    "5c34a029da8336e21a000003": "brain and kidney",
    "5be94f3d133db5eb78000022": "bladder cancer",
    "5c34a761da8336e21a000005": "estrogen",
    "5be44d8b133db5eb78000015": "Pseudomonas",
    "5be2a070133db5eb78000013": "adipose",
    "5c0e82b2133db5eb7800002d": "CLEC11A",
    "5c61cdd7e842deac67000004": "rilpivirine",
    "5c61f379e842deac67000006": "c.1482delinsGCCAGG",
    "5c72d4c77c78d6947100007c": "Nup60",
    "5c641179e842deac67000012": "increases nuclear height and impairs nuclear re-orientation",
    "5c53131e7e3cb0e231000012": "Coryza",
    "5c641c60e842deac67000013": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene2, matchbox",
    "5c5315727e3cb0e231000014": "Axl, and Mer",
    "5c645313e842deac67000019": "loss of self-avoidance",
    "5c6ffdd47c78d69471000058": "miR-423-5p",
    "5c5f11c31a4c55d80b000015": "Larp7",
    "5c654b3de842deac67000024": "Multiple Myeloma",
    "5c658a8f7c78d69471000007": "diarrhea",
    "5c76c1457c78d694710000a6": "birdshot chorioretinopathy, Beh\u00e7et's disease",
    "5c6e146a7c78d6947100004c": "glecaprevir/pibrentasvir",
    "5c61bd04e842deac67000002": "valsartan-sacubitril",
    "5c6585287c78d69471000004": "acute myeloid leukemia",
    "5c73ad087c78d69471000091": "ivacaftor",
    "5c6c46677c78d69471000035": "NanoStringNormCNV",
    "5c76e6d27c78d694710000ac": "early endosome antigen 1",
    "5c0119f3133db5eb7800002b": "Klebsiella pneumonia",
    "5c7036127c78d69471000064": "Robotic Cystectomy",
    "5c5214207e3cb0e231000003": "development of drugs against disease-associated genes",
    "5c7ab080d774d0424000000b": "dimethylxanthenone-4-acetic acid",
    "5c6dfdf27c78d69471000047": "nivolumab plus ipilimumab",
    "5c6e01af7c78d69471000048": "cytomegalovirus infection and disease after stem cell transplant",
    "5c544c1707647bbc4b000003": "AsCNAR",
    "5c6b7daa7c78d6947100002b": "telangiectasias",
    "5c561da707647bbc4b00000f": "tmvar",
    "5c57041807647bbc4b000015": "inflammation and metabolism",
    "5c56bbb107647bbc4b000011": "tmVar",
    "5c6f107c7c78d69471000051": "FAK",
    "5c6ffa257c78d69471000056": "NAGLU",
    "5c580fe107647bbc4b00001b": "esophageal squamous cell carcinoma",
    "5c58282e07647bbc4b00001e": "mmquant",
    "5c596ad686df2b9174000015": "ITGA4",
    "5c72a9147c78d6947100006e": "Trifluridine",
    "5c72b6be7c78d69471000072": "phosphoinositide 3-kinase-\u03b4",
    "5c78174b7c78d694710000b1": "MyriMatch",
    "5c62a276e842deac6700000a": "PRKCD, and C1QTNF4",
    "5c7034ae7c78d69471000063": "dolutegravir",
    "5c928958ecadf2e73f000017": "single-reaction multiplexing",
    "5c63286ae842deac6700000e": "amegakaryocytic thrombocytopenia",
    "5c72fb4a7c78d69471000082": "achalasia",
    "5c8d00980101eac870000006": "nicotinamide",
    "5c8d0a980101eac870000008": "p16INK4a",
    "5c73acf57c78d6947100008c": "Trouble",
    "5c5f0f581a4c55d80b000012": "Th17 cells",
    "5c73ad057c78d6947100008f": "palonosetron",
    "5c5f2dc21a4c55d80b000024": "serotonin",
    "5c851a8175a4a5d219000005": "toxin B",
    "5c7d520ed774d0424000000f": "leptin",
    "5c73ace67c78d69471000083": "osteodystrophy",
    "5c6d6b377c78d69471000039": "pedigreejs",
    "5c6d783e7c78d6947100003a": "ArachnoServer",
    "5c851c2675a4a5d219000006": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab",
    "5c8bfe25d558e5f23200000f": "modulates the host immune-inflammatory response and bone metabolism",
    "5c900983ecadf2e73f000002": "patisiran",
    "5c6b15467c78d69471000024": "IntMAP",
    "5c6bda9d7c78d69471000031": "MGA",
    "5c73ad0f7c78d69471000096": "ocular hypertension and open-angle glaucoma",
    "5c6c497d7c78d69471000036": "FlatNJ",
    "5c88550075a4a5d219000008": "COG133",
    "5ca60a77ecadf2e73f00004d": "enhancers",
    "5c8c095e0101eac870000002": "macrophages",
    "5c9d18f1ecadf2e73f000033": "OPRM1",
    "5c961603ecadf2e73f000022": "tocilizumab",
    "5c890ff475a4a5d219000010": "bronchitis and bronchial asthma",
    "5c979ffcecadf2e73f000028": "Toxocara canis",
    "5c97f579ecadf2e73f00002a": "retina",
    "5c9f79c3ecadf2e73f00003d": "IgA, and IgG",
    "5c9fb583ecadf2e73f000042": "Why we build models of human performance",
    "5ca9f932ecadf2e73f000054": "bacterial gene expression",
    "5ca64b5becadf2e73f000051": "moesin (ERM proteins)Ezrin/radixin/moesin",
    "5c9007460101eac870000012": "Cfl2",
    "5c990afbecadf2e73f000030": "TRAF6",
    "5c9d170cecadf2e73f000032": "obesity",
    "5c961281ecadf2e73f000021": "interstitial lung disease"
}
